DLHC
Get informed when a big investor buys or sells
+ FollowUndervalued by 212.8% based on the discounted cash flow analysis.
| Market cap | $67.54 Million |
|---|---|
| Enterprise Value | $208.45 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.09 |
| Beta | 1.46 |
| Outstanding Shares | 14,388,000 |
| P/E Ratio | -3.09 |
|---|---|
| PEG | 0.05 |
| Price to Sales | 0.28 |
| Price to Book Ratio | 0.79 |
| Enterprise Value to Revenue | 0.82 |
| Enterprise Value to EBIT | -306.99 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.68 |
| Debt to Equity | 1.51 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 66.17%▼ 1.13% |
|---|---|
| Total Invested | $55.41M▲ 1.28% |
| Investors Holding | 43▼ 2.00% |
No data
DLH is a comprehensive health solutions and services provider that delivers a full range of technology-enabled health services across various civilian agencies, the military health system, and the Veterans Administration. The Company's s...